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Objective. This study examines how "strategic partnerships" between community-based
consortia of oncologists and hospitals (CCOPs) and clinical cooperative groups emerge,
develop, and influence patient accruals (i.e., the number of patients enrolled in clinical
trials) over time.
Data Sources and Study Setting. Study analyses are based on 65 pairwise relationships
that 38 CCOPs established with eight clinical cooperative groups in September 1983 and
maintained through February 1989. Data are drawn from grantee applications and
progress reports.
Study Design. The study examines how different types of CCOP-cooperative group
exchange relate to one another and to CCOP patient accruals over six time points. Key
independent variables include resource dependence, information exchange (i.e., meeting
attendance and committee membership), and protocol exchange (i.e., the number of
different protocols used).
Data Collection Methods. Data extracted from secondary sources were entered in a
data base.
Principal Findings. The number of CCOP physicians and support staff who attend
cooperative group meetings during the first two years of a clinical research partnership
has a significant influence on meeting attendance and protocol use in later years. Two-
thirds or more of the variance in patient accruals at each time point can be explained by
the number of different protocols used and the number ofCCOP representatives serving
on cooperative group committees (or attending cooperative group meetings).
Conclusions. The findings highlight the importance of historical relationships and antic-
ipated resource dependence in shaping initial exchange patterns. They also suggest that
strategic partnerships need to emphasize structures and processes that encourage early
involvement in collaborative activities and that reward participants for maintaining high
levels of interaction.
Keywords. Community Clinical Oncology Program, strategic partnerships, clinical
cooperative groups, interorganizational relations
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In recent years, health services researchers and practitioners have
noted the proliferation of "strategic partnerships" in the health services
sector. These partnerships include hospital and health service alliances,
organ procurement networks, hospital-physician joint ventures, and
technology development alliances between university and industrial
scientists. Luke, Begun, and Pointer (1989) identify two characteristics
that make these partnerships unique: (1) the "loose coupling" that ties
the collaborating organizations together and (2) the importance and
permanence of their strategic purposes. They and others (Kaluzny and
Zuckerman 1992) point out that both conceptual and empirical work
are lacking on these interorganizational alliances.
What appears to be a new kind of cooperative strategy for health
service organizations is, in fact, a tradition in the realm of cancer clinical
research. For more than 35 years, clinical cooperative groups have
been pooling knowledge and resources to develop new cures for cancer.
These experiences, along with their more recent efforts to transfer new
diagnostic and treatment technologies to community medical practices,
make the cooperative groups prototypes for studying strategic partner-
ships. This article explores issues surrounding the development and
performance of strategic partnerships within the context of a federally
sponsored Community Clinical Oncology Program, which links com-
munity oncologists with clinical research programs in cancer centers
and clinical cooperative groups.
BACKGROUND
In September 1983, the National Cancer Institute (NCI) introduced
the Community Clinical Oncology Program as a mechanism for dis-
seminating state-of-the-art cancer treatments and patient management
techniques to community oncologists and their patients. Spurred by
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congressional concern that the billions of dollars being spent on cancer
research were having only minimal impact on cancer incidence and
mortality, the Community Clinical Oncology Program sought to accel-
erate the transfer of research findings to community settings where
more than 80 percent of all cancer patients are treated. A second
(CCOP-II) funding cycle, initiated in June 1987, expanded the pro-
gram's focus to include research on cancer prevention, screening and
early detection, continuing care, and rehabilitation. Both funding
cycles awarded cooperative agreements to community-based consortia
of oncologists and hospitals (i.e., CCOPs) to enroll patients in clinical
trials through cancer centers and clinical cooperative groups that the
NCI had designated as CCOP "research bases." These CCOP-research
base alliances function as "R&D partnerships," with research bases
designing and monitoring the clinical trials, and the CCOPs contribut-
ing to knowledge development by enrolling patients and providing
feedback on patient responses to different treatment regimens.
The application guidelines for the Community Clinical Oncology
Program require each CCOP to affiliate with at least one, but no more
than five, NCI-supported research bases for the purpose of enrolling
patients in cancer treatment and cancer control clinical trials. Patients
who participate in these clinical trials receive the state-of-the-art thera-
pies or cancer control interventions through participating CCOP
oncologists in their local communities. The interactions between a
CCOP and its research base(s) have different relational contents
(Hakansson 1982). Information exchange occurs when CCOP repre-
sentatives attend research base meetings, serve on scientific and
administrative committees, participate in on-site data audits, and
exchange written reports and correspondence. Resource exchanges
include the exchange of research protocols and the enrollment of
patients in clinical trials.
In the decade since the Community Clinical Oncology Program
has become operational, some clinical cooperative groups have encour-
aged CCOP physicians to join their scientific committees, to design
protocols for the administration of clinical trials, and to chair clinical
research studies, while others have discouraged, or given only weak
support, to such participation. Likewise, some CCOPs have actively
sought major involvement in cooperative group scientific activities
while others have functioned strictly as "patient contributors." These
different interaction strategies appear to have important implications
for CCOP performance; yet no one has examined how different types
and levels of exchange between CCOPs and their cooperative groups
affect a key performance measure -the number of patients enrolled in
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clinical trials. This study draws upon interorganizational theory to
develop and test hypotheses about how CCOP-research base relation-
ships emerge, develop, and influence patient accruals (i.e., the num-
ber of patients enrolled in clinical trials) over time. The findings have
implications, not only for National Institutes of Health-sponsored clin-
ical research partnerships but also for the broader health services
research community, which seeks to understand the kinds and levels of




Interorganizational theory suggests that a CCOP will enter into an
exchange relationship with a research base to gain access to critical
resources such as protocols, investigational drugs, and experiential
knowledge (Kogut 1988; Powell 1990). Because much of the required
knowledge is embedded in the experience and skills of group investiga-
tors (Osborn and Baughn 1990), CCOP representatives need to attend
research base meetings and serve on scientific committees in order to
tap into these information sources. The greater the resource depen-
dence, the more the two organizations should communicate with each
other as they try to assess the other's resources, capabilities, and expec-
tations (Ford 1982; Van de Ven and Walker 1984). Thus, resource
dependence should be positively associated with the "extensity" of ini-
tial information exchanges (Hallen, Mohamed, and Johanson 1989),
as measured by the number of CCOP representatives who participate
in meetings and committees.
Since resource dependence reflects the extent to which a CCOP
expects to participate in group trials, the level of resource dependence
should have a direct bearing on the number of different protocols used.
CCOP oncologists see patients with different tumor types and in dif-
ferent stages of disease. Even when patients have the same tumor type,
they may require different protocols because of their age, medical
history, or performance status. These variations in patient characteris-
tics suggest that a CCOP that is highly dependent on one research
base's protocols will need to use a greater range of protocols (i.e.,
engage in "wider" protocol exchange) to meet different patient needs.
Therefore,
Interorganizational Exchanges 463
Hypothesis 1. Resource dependence at the onset of the relationship will be
positively associated with initial levels of information and
protocol exchange.
EXCHANGE RELATIONSHIPS
By attending research base meetings and serving on scientific commit-
tees, CCOP physicians and support staff obtain important information
on the objectives, eligibility requirements, and treatment plans of new
clinical trials. The importance of these information exchanges is illus-
trated by the following comment from a clinical investigator:
The perception [that multicenter trials can be conducted with little or no
contact between investigators] is based on the antiseptic view that the
protocols of trials and the treatment processes can be carried out by a
series of cut and dried steps that, once established, can be followed more
or less by rote. Overlooked in this view is the importance of dialogue,
debate, and consensus formation as a means of establishing and main-
taining a spirited, quality-conscious investigatorship. The quality and
success of a trial depends on having trained people with detailed knowl-
edge of the protocol. It is not possible to achieve and maintain that kind
of familiarity without continuing contact through regular face-to-face
meetings, usually more frequently than once a year. (Meinert 1990, 400)
Cunningham and Turnbull (1982) observe that information
exchanges usually precede the exchange of products (protocols in this
study). Participation in research base meetings and on scientific com-
mittees helps to resolve uncertainties that CCOP physicians may have
about the scientific merit of new studies or the feasibility of certain
protocols for community application. As uncertainty is reduced, so is
the perceived risk of enrolling patients on the research protocols.
Face-to-face meetings between CCOP and university-based inves-
tigators also provide opportunities for joint protocol development,
making it possible for research base studies to be better adjusted to the
needs of the "using systems" (Mattsson 1978, p. 212). The more oppor-
tunities that CCOP physicians have to plan and revise research proto-
cols, the more receptive they should be to testing different protocols
(Hakansson 1987). "Wide" protocol exchange should, in turn, lead to
more extensive information exchange because the two organizations
have to know more about each other's performance, problems, and
findings (Hallen, Johanson, and Mohamed 1987; Lazerson 1988).
This suggests that
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Hypothesis 2. Information exchange and protocol exchange will be
positively and reciprocally related over time.
Interdependencies between a CCOP and a research base require
that the two organizations coordinate their activities (Johanson and
Mattsson 1987). This coordination can be achieved through an ongo-
ing information exchange process in which the two organizations each
learn about the other's capabilities and limitations, and assess whether
or not the interorganizational match is, in fact, a good one (Fichman
and Levinthal 1991). Research base scientific sessions and committee
meetings accelerate the flow of information by bringing CCOP and
university-based investigators into direct contact with one another and
by encouraging them to develop a common language and framework
for solving complex scientific problems (Daft and Lengel 1984). These
information exchanges should build interorganizational contact pat-
terns that encourage further investments in the relationship (Larson
1992; Wilson and Mummalaneni 1986).
As a CCOP-research base relationship evolves, the links between
the organizations should grow stronger and more stable (Hakansson
and Johanson 1988). Information exchanges acquire value- not just as
sources of technical knowledge but as sources of relationship knowl-
edge and personal satisfaction (Kanter 1989). When information
exchanges enhance the intrinsic worth of a CCOP-research base rela-
tionship, they are likely to be repeated (Scott 1987) and to grow in
strength over time. Therefore,
Hypothesis 3. Information exchange in one period will be positively
associated with information exchange in the next period,
and this positive association will grow stronger over time.
EXCHANGES AND ACCRUAL
PERFORMANCE
Meeting attendance and committee service build information channels
between a CCOP and its research base at several organizational levels
(e.g., principal investigators, physicians, oncology nurses, and data
managers). The more representatives a CCOP sends to research base
and scientific committee meetings, the more opportunities it has to
acquire information on new methods of cancer detection and treat-
ment. The strong ties created through these information exchanges
help to reduce the distance between the CCOP and the research base
(Hallen, Johanson, and Mohamed 1987), thereby increasing both the
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speed and credibility of the information flow. Repeated interactions
with research base investigators who are participating in new clinical
trials also provide legitimation and support for the studies, creating
strong peer pressures to enroll patients in the trials (Anderson and Jay
1985). This positive relationship between information exchange and
accrual performance is demonstrated by the Community Cancer Care
Evaluation of CCOP-I, which found a "clear trend toward increased
[meeting] attendance by the more successful CCOPs" (Feigl, Patmont,
Rodenbaugh, et al. 1987, 20).
When CCOP physicians use many different research protocols
(i.e., engage in "wide" protocol exchange), they should find it easier to
match patients with protocols and, thus, to boost patient enrollments.
The willingness to try different protocols also reduces a CCOP's depen-
dence on a few clinical research studies so that accrual performance can
be maintained even when these studies close. The Community Cancer
Care Evaluation's discovery of a positive relationship between the
number of distinct protocols used per unit time and CCOP patient
accruals lends support to this argument (Feigl, Patmont, Rodenbaugh,
et al. 1987). Consequently,
Hypothesis 4. Information exchange and protocol exchange will be
positively associated with CCOP accrual performance
over time.
METHODS
The hypotheses predict how two types of CCOP-research base
exchange-one involving information and the other protocols-will
relate to one another and to CCOP patient accruals over time. Since
the interaction between a CCOP and a research base is the topic of
interest, the unit of analysis is the CCOP-research base relationship. If
a CCOP is affiliated with three research bases, for example, each
affiliation constitutes a separate relationship.
The study period covers six time points that span two Community
Clinical Oncology Program funding cycles - CCOP-I and CCOP-IL. A
"pre-CCOP" time point (t0) includes measures of a CCOP's relation-
ship with its research base in the year before the CCOP-I award.
Through programs such as the Cooperative Group Outreach Program
(CGOP), some community oncologists began accruing patients to
cooperative groups' clinical trials before the Community Clinical
Oncology Program became operational.' The remaining time points
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(tl-t6) correspond to reporting periods established by the NCI for the
purpose of monitoring patient accruals.
SAMPLE SELECTION
Study analyses are based on 65 pairwise relationships that 38 CCOPs
established with eight clinical cooperative groups in September 1983
(the beginning of the CCOP-I funding cycle) and maintained through
February 1989 (the end of the second reporting period of CCOP-II).
The cooperative groups represent the major multidisciplinary and spe-
cialty research bases that participated in both CCOP-I and CCOP-TI.2
The six other research bases that participated in CCOP-I and CCOP-II
are NCI-supported cancer centers that design most protocols in-house.
VARIABLES AND MEASURES
CCOP performance is measured by the number of patients that a
CCOP enrolls in a cooperative group's clinical trials during a reporting
period. The hypotheses focus on three independent variables: resource
dependence, information exchange, and protocol exchange. Resource
dependence refers to a CCOP's need to interact with a cooperative
group to acquire needed resources. The level of resource dependence at
the onset of a CCOP-research base relationship is measured by the
proportion of a CCOP's total projected patient enrollments that is
attributable to a particular cooperative group.
Two measures of information exchange are employed: (1) the
number of physicians, nurses, and data managers from the CCOP who
attend at least one cooperative group meeting during a reporting
period, and (2) the number of CCOP representatives who serve on at
least one cooperative group committee during a reporting period.
These information exchanges require different kinds and amounts of
involvement and, therefore, represent different levels of relationship
intensity.
CCOPs enter into affiliation agreements with cooperative groups
to gain access to research protocols. The level of protocol exchange in
each CCOP-research base relationship is measured by the number of
different cancer treatment protocols to which the CCOP accrues at
least one patient during a reporting period.
Because CCOP-research base interactions may be influenced by
the characteristics of the interacting organizations, this study includes
pre-CCOP clinical trials experience and CCOP size as additional
explanatory variables. Previous experience in working together can
affect the level of importance attached to the relationship and, thus, the
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extent to which the two organizations interact. As measures of pre-
CCOP clinical trials experience, this study uses (1) the number of
patients enrolled by CCOP physicians in a cooperative group's clinical
trials, through the CGOP and other programs, in the year prior to the
CCOP-I award, and (2) a ratio of the number of physicians in the
CCOP who enrolled patients in a cooperative group's clinical trials in
pre-CCOP years to all physicians listed in the CCOP's cooperative
agreement application. CCOP size is operationalized as (1) the num-
ber of physicians in the CCOP who enrolled patients in clinical trials
during a reporting period and (2) the total number of physicians who
participated in the CCOP during a reporting period, including those
who referred patients to CCOP oncologists or assisted with patient
diagnoses.
DATA SOURCES AND ANALYSIS
Study data were collected from grantee applications and progress
reports as part of a larger evaluation of the Community Clinical Oncol-
ogy Program. Pearson correlations and regression models were used to
test hypothesized relationships between variables.3 Depending upon
the hypothesis, relationships between variables were tested in the same
reporting period or in adjoining periods. Secondary analyses examined
whether regression models could be improved by adding either mea-
sures of CCOP size, pre-CCOP clinical trials experience, or both, as
additional explanatory variables.
RESULTS
Hypothesis 1 predicts that resource dependence at the onset of the
relationship will be positively associated with initial levels of informa-
tion and protocol exchange. Table 1 suggests that resource dependence
has a greater influence on the "width" of protocol exchange than on the
"extensity" of information exchange. Three factors account for more
than three-quarters of the variance in the number of cancer treatment
protocols used at t1: (1) the CCOP's level of resource dependence, (2)
the number of CCOP representatives attending cooperative group
meetings during the first reporting period, and (3) the CCOP's pre-
vious experience with the cooperative group's clinical trials as mea-
sured by pre-CCOP patient accruals (i.e., the number of patients enrolled
in clinical trials in the pre-CCOP year) and the MD experience ratio (i.e.,
the proportion of CCOP physicians that enrolled patients in the coop-
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Table 1: Predictors of Time 1 CCOP-Research Base
Exchanges, Unstandardized Coefficients Reported
(N = 62 CCOP-Research Base Relationships)
Protocol Meeting Committee
Exchange t1 Attendance t1 Membership t1
Independent Model Model Model
Variables 1 2 3
Constant -.566 -.912 -.268
Resource dependence to 12.316*** 6.055*** 1.765**
Pre-CCOP patient accruals to .130*** .041**
No. serving on committees t1 .736**
Total MDs t1 .1 12*
No. attending meetings t, .751* *
MD experience ratio to 7.061*
R2 .774 .565 .569
Adjusted R2 .758 .542 .554




erative group's clinical trials in pre-CCOP years). Resource depen-
dence, meeting attendance, and experience with the cooperative group
seem to build a "comfort factor for risk taking" (Quinn 1978, 11) that
encourages CCOP physicians to take greater advantage of the array of
protocols available to them.
The conditions leading to different types of information exchange
during the early stage of a CCOP-research base relationship are less
clear. Model 2 in Table 1 suggests that a little more than half of the
variance in the number of CCOP representatives attending coopera-
tive group meetings at t1 can be explained by three factors: (1) the
CCOP's level of resource dependence, (2) the number of CCOP repre-
sentatives serving on cooperative group committees during the first
reporting period, and (3) the total number of physicians participating
in the CCOP. As predicted by Hypothesis 1, resource dependence
provides a strong incentive to obtain firsthand information on coopera-
tive group protocols and procedures. The statistical significance of
committee membership suggests that the CCOP physicians and sup-
port staff who are most actively involved in clinical research will be the
first to attend cooperative group meetings. CCOP size reflects both the
breadth of interest in clinical research and the amount of human and
financial resources that can be allocated to relationship development.
Fifty-five percent of the CCOP-research base relationships had no
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CCOP representatives as committee members during the first report-
ing period. Model 3 in Table 1 shows that, together, resource depen-
dence and the number of patients accrued in the pre-CCOP year
account for 55 percent of the variance in t1 committee membership.
While resource dependence provides some incentive to join cooperative
group committees, the high statistical significance of pre-CCOP
accrual performance (t = 6.48, p < .001) suggests that CCOP physi-
cians are more likely to seek (and receive) early committee appoint-
ments when they have established accrual track records with the
cooperative group through the CGOP and other pre-CCOP relation-
ships.
The hypothesis that information exchange and protocol exchange
will be positively and reciprocally related over time is most strongly
supported when meeting attendance is used as the information
exchange measure. As shown in Table 2, the positive association
between the number of CCOP representatives attending cooperative
group meetings and the number of different cancer treatment protocols
used is .60 or higher during four of the six reporting periods. The
associations are particularly strong during the first reporting period of
CCOP-I (tl), the extension period between CCOP-I and CCOP-II (t4),
and the second reporting period of CCOP-II (16). At times 2, 3, 5, and
6, the number of cancer treatment protocols used is most highly corre-
lated (r 2 .65) with the number of CCOP representatives attending
cooperative group meetings at t.4 This finding suggests that the level
of meeting attendance during the first year of a CCOP-research base
relationship has an important influence on the number of cancer treat-
ment protocols used in subsequent years. As the relationship evolves,
continued meeting attendance helps to sustain protocol exchange by
providing both information on new protocols and updates on the status
of ongoing studies.
Although the number of CCOP representatives serving on coop-
erative group committees is positively associated with the number of
different cancer treatment protocols used at each time point, the rela-
tionships are weaker than those observed for meeting attendance and
protocol exchange. In every reporting period, protocol exchange is
most highly correlated (r 2 .52) with the number ofCCOP representa-
tives serving on cooperative group committees at tl. There are also
fairly strong relationships (r 2 .53) between the number of different
cancer treatment protocols used at t1 and the number of CCOP repre-
sentatives serving on committees (or attending meetings) in succeeding
reporting periods. These findings suggest that the reciprocal relation-
ship between information exchange and protocol exchange extends
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over time, with the initial levels of exchange setting standards for
subsequent CCOP-research base exchanges.
Hypothesis 3 predicts that information exchange in one period
will be positively associated with information exchange in the next
period and that this positive association will grow stronger over time.
Table 2 displays correlations between the information exchange mea-
sures across the six reporting periods. As predicted, the positive associ-
ation between the number of CCOP representatives serving on
cooperative group committees at ti and the number serving on commit-
tees at ti+ 1 grows stronger over the study period. With the exception of
committee membership at t4 and t5, there is a steady increase in the size
of the correlation coefficients from .84 (t1 and t2) to .99 (t5 and t6).
Although meeting attendance at ti is positively associated with
meeting attendance at ti+, these associations grow weaker over the
study period. At t4 and t6, the number ofCCOP representatives attend-
ing cooperative group meetings is more strongly associated with meet-
ing attendance at t1 and t2 than with meeting attendance in the previous
period. The number of CCOP representatives attending cooperative
group meetings at t5 also shows a rather strong correlation (r = .60)
with meeting attendance at t2. These findings highlight an important
distinction between meeting attendance and committee membership
trends. While meeting attendance patterns appear to be established
during the first two years of a CCOP-research base relationship, com-
mittee membership patterns seem to evolve more slowly over time.
Because committee membership requires a higher level of involvement
in group scientific activities, CCOP representatives are not likely to
seek (or receive) committee appointments until they are familiar with
and committed to the group's research agenda.
The positive associations between committee membership at ti and
meeting attendance at ti+ 1 generally are weaker than those for meeting
attendance at ti and meeting attendance at ti +1. In the last three report-
ing periods, the number of CCOP representatives attending coopera-
tive group meetings shows a stronger association with meeting
attendance at t1 and t2 than with committee membership in the pre-
vious period.
Throughout the study period, the positive associations between
meeting attendance at ti and committee membership at ti+ 1 are notably
weaker than those for committee membership at ti and committee
membership at ti+ 1. However, Table 2 reveals strong relationships (r 2
.87) between the number ofCCOP representatives attending coopera-
tive group meetings at t3 and the number serving on committees in
subsequent reporting periods. Although Table 2 does not display corre-
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lations between meeting attendance and protocol chair appointments,
it is interesting to note that, in the last three reporting periods, the
number of CCOP representatives chairing research protocols is more
highly correlated (r 2 .61) with t3 meeting attendance than with meet-
ing attendance in any other reporting period. These associations sug-
gest that the level of meeting attendance in the third year of a
CCOP-research base relationship may be a good "marker" of subse-
quent CCOP involvement in group scientific activities.
The hypothesis that information exchange and protocol exchange
will be positively associated with CCOP accrual performance receives
strong support throughout the study period. As shown in Table 3, two-
thirds or more of the variance in patient accruals at each time point can
be explained by the number of different cancer treatment protocols
used and the number ofCCOP representatives serving on cooperative
group committees (or attending cooperative group meetings). The pro-
portion of explained variance is especially high (> 80%) during the
first two reporting periods of CCOP-I and the first reporting period of
CCOP-II. This finding suggests that information and protocol
exchanges have a particularly strong influence on CCOP accrual per-
formance when a CCOP-research base relationship is being formed or
reorganized. By promoting communication and cooperation, these
exchanges help the two organizations to overcome the "liabilities of
newness" that threaten initial performance and that re-emerge when
roles and routines undergo reorganization (Hannan and Freeman
1984). The inclusion of CCOP size measures in the aforementioned
models adds little to their explanatory power.
DISCUSSION AND
IMPLICATIONS
The foregoing analyses of CCOP-cooperative group exchanges can be
compared to biochemists' attempts to find "tumor markers" that are
useful in diagnosing early cancers or to the Joint Commission on
Accreditation of Healthcare Organizations' search for organizational
indicators that predict clinical outcomes. If each type of exchange is
viewed as a "marker" of future CCOP performance, it is possible to
identify critical points in the relationship development process when
carefully planned interventions can increase community physicians'
participation in clinical trials research. These findings have several
policy implications for the Community Clinical. Oncology Program
and for other kinds of health care strategic partnerships.
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For community-based health research initiatives, such as the
Community Clinical Oncology Program and the Community Pro-
grams for Clinical Research on AIDS, the study findings suggest that
the number of community clinicians who attend scientific meetings in
the first two years of the clinical research partnership has a significant
influence on meeting attendance and protocol use in later years. The
more community clinicians participate in scientific meetings and diver-
sify their protocol use, the higher their accrual performance should be.
The National Institutes of Health could encourage more community
clinicians to attend scientific meetings by increasing the travel compo-
nent of grant awards and/or by requiring a local match for physician
and staff travel. Clinical research groups could promote higher meet-
ing attendance by offering more scientific sessions and workshops on
topics that are of interest to community-based practitioners, seeking
higher continuing medical education credits for meeting participation,
and giving points for meeting attendance in the performance review
process.
This study also suggests that the participation of community clini-
cians on protocol design and monitoring committees stimulates higher
accrual performance. Since committee membership requires a greater
commitment of time and effort than meeting attendance, the clinical
research groups may need to take special steps to encourage early par-
ticipation by community clinicians. These steps might include (1)
forming "new investigator" committees to stimulate interest in group
clinical trials and research opportunities, (2) inviting community-based
physicians and nurses to meet with committee chairs and participate in
protocol reviews, and (3) asking community-based "opinion leaders"
who are strongly committed to clinical research to help recruit some of
their colleagues for committee service. Broader protocol use could be
encouraged by simplifying protocol eligibility criteria, minimizing the
amount of time that must be spent on test scheduling and patient
follow-up, and eliminating laboratory tests and other protocol require-
ments that impose unreasonable cost burdens on study subjects.
Although the dyadic interactions between community-based prac-
titioners and clinical research groups are the focus of this study, other
environmental influences that may mediate these relationships need to
be examined. Vertical linkages with agencies such as the NCI, the
Food and Drug Administration, and pharmaceutical companies need
to be considered along with lateral linkages with primary care and
specialty physicians, members of affected communities, and hospital
institutional review boards. The more the expectations and demands of
these entities conflict with one another, the less responsive community
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clinicians may be to interventions designed to increase their participa-
tion in clinical trials research.
This study also has implications for the broader health care arena
where strategic partnerships such as managed care systems, trauma
networks, and technology development alliances between university
and industrial scientists are becoming increasingly common. The find-
ings highlight the importance of historical relationships and anticipated
resource dependence in shaping initial exchange patterns. They also
suggest that strategic partnerships need to emphasize structures and
processes that encourage early involvement in collaborative activities
and that reward participants for maintaining high levels of interaction.
Exchange patterns established during the early years of a strategic
partnership seem to "imprint" the relationship with performance stan-
dards and relational expectations that persist over time.
This study offers evidence that early communication on each part-
ner's needs, expectations, and priorities is critical to the development of
a successful strategic partnership. This is particularly true when the
partners have different missions, professional philosophies, and oper-
ating procedures. The designation of"boundary role persons" to partic-
ipate in joint meetings and plan collaborative activities allows the
organizations to become familiar with each other's ways of working and
to develop shared perceptions of each other's needs and offers. Future
studies need to investigate how turnover among these boundary role
persons affects the length of time required for relationship develop-
ment and the performance of the strategic partnership.
Finally, the study suggests that the formation of a strategic part-
nership takes much mote time than is generally recognized by funders
and policymakers. Government agencies and private foundations often
expect a strategic partnership to be fully operational in the first year of
funding when, in fact, the relationship may take years to develop.
Repeated interactions and mutual adaptations are needed to build
confidence in the relationship at both personal and organizational lev-
els. The incremental nature of the relationship development process
suggests that evaluations of health care strategic partnerships need to
be longitudinal, process-oriented, and attentive to exchanges that may
be "markers" of future performance.
NOTES
1. The NCI established the Cooperative Group Outreach Program in 1976 to
involve community oncologists and their patients in clinical trials. Con-
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tracts are awarded, on a competitive basis, to cooperative groups to pro-
vide data management support to participating community oncologists and
to cover the costs of data analysis and quality control systems.
2. The clinical cooperative groups include the Cancer and Leukemia Group B
(CALGB), the Eastern Cooperative Oncology Group (ECOG), the South-
west Oncology Group (SWOG), the North Central Cancer Treatment
Group (NCCTG), the National Surgical Adjuvant Project for Breast and
Bowel Cancers (NSABP), the Radiation Therapy Oncology Group
(RTOG), the Children's Cancer Study Group (CCSG), and the Pediatric
Oncology Group (POG).
3. Like other empirical studies of interorganizational exchanges, this study's
use of the CCOP-research base relationship as the unit of analysis violates
the linear regression assumption that the error terms are uncorrelated.
Since a CCOP can affiliate with more than one cooperative group, the
outcome in one CCOP-cooperative group exchange may affect the out-
come in another CCOP-cooperative group exchange. Among the 38
CCOPs studied, 18 (47 percent) maintained affiliations with just one coop-
erative group, 14 (37 percent) maintained two affiliations, five (13 per-
cent) maintained three affiliations, and one CCOP had four cooperative
group affiliations. The authors considered using the jackknife technique or
Monte Carlo analyses to address this potential problem but concluded that
the study sample was not of sufficient size to apply these techniques appro-
priately. Therefore, a decision was made to use the more conservative
significance level of p < .01 in interpreting study results.
4. Protocol exchange at t6 also shows a strong association (r = .75) with t4
meeting attendance.
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